Peetz Christopher sold MIRM
August 10, 2026 · Form 4 insider transaction
Peetz Christopher sold 11,683 shares of Mirum Pharmaceuticals, Inc. at $98.51 per share, a transaction worth $1.15M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
11,683
Price
$98.51
Total value
$1.15M
InsiderPeetz Christopher
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 10, 2026
Filing dateAugust 11, 2026
Shares owned after202,626
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2026.; The weighted average sale price for the transaction reported was $98.51, and the range of prices were between $97.93 and $98.92. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.